Europe Fish Vaccines Market Forecast to 2030

Europe Fish Vaccines Market Forecast to 2030 – Regional Analysis – by Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Recombinant Vector Vaccine, and Others), Application (Bacterial Infection, Viral Infection, and Parasitic), Route of Administration (Injection Vaccine, Immersion Vaccine, and Oral Vaccine), and Species (Salmon, Trout, Tilapia, and Others)

Send Enquiry
Item ID: BMIRE00029703 Category: Tag:

$2,840$4,440

Description

The Europe fish vaccines market was valued at US$ 110.00 million in 2022 and is expected to reach US$ 191.33 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Surging Demand for Aquatic Animal-Derived Food Products Fuel the Europe Fish Vaccines Market

An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet. Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.

Europe Fish Vaccines Market Overview

The European fish vaccines market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the fish vaccines market. The European fish vaccines market is expected to witness significant growth during the forecast period due to factors such as the significant growth in aquaculture industry, surging demand for aquatic animal-derived food products, growing research and development activities for fish vaccines development by market players in the region. Aquaculture is one of the key food-production sectors in the UK. According to the Department of Business and Trade (UK), seafood purchase is estimated to be ~US$ 5.14 billion in Great Britain. According to Innovate UK, the production value of the aquaculture industry in the UK is ~US$ 730.88 annually. Various events are organized by regulatory authorities to increase the awareness regarding the importance of maintaining aquaculture and fisheries. In May 2023, the UK’s largest trade show-Aquaculture UK-for the community of aquaculture was held in Aviemore, Scotland. This trade show focused on innovation and sustainability in fish health, cleaner fish breeding, genetic selection, and other topics.

Europe Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Europe Fish Vaccines Market Segmentation

The Europe fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Europe fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Europe fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Europe fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Europe fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Europe fish vaccines market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe fish vaccines market share in 2022.

Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Europe fish vaccines market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.2% CAGR, the Europe Fish Vaccines Market is Speculated to be worth US$ 191.33 million by 2030, says the Research Team

According to the Research Team’ research, the Europe fish vaccines market was valued at US$ 110.00 million in 2022 and is expected to reach US$ 191.33 million by 2030, registering a CAGR of 7.2% from 2022 to 2030. Government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products are the critical factors attributed to the Europe fish vaccines market expansion.

Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies. Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.

On the contrary, stringent regulations for approval of vaccine hurdles the growth of Europe fish vaccines market.

Based on vaccine type, the Europe fish vaccines market is categorized into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held 72.0% market share in 2022, amassing US$ 79.22 million. It is projected to garner US$ 139.76 million by 2030 to expand at 7.4% CAGR during 2022-2030.

Based on application, the Europe fish vaccines market is categorized into bacterial infection, viral infection, and parasitic. The bacterial infection segment held 80.8% share of Europe fish vaccines market in 2022, amassing US$ 88.88 million. It is projected to garner US$ 156.26 million by 2030 to expand at 7.3% CAGR during 2022-2030.

Based on route of administration, the Europe fish vaccines market is categorized into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held 59.8% share of Europe fish vaccines market in 2022, amassing US$ 65.74 million. It is projected to garner US$ 113.72 million by 2030 to expand at 7.1% CAGR during 2022-2030.

Based on species, the Europe fish vaccines market is categorized into salmon, trout, tilapia, and others. The salmon segment held 71.8% share of Europe fish vaccines market in 2022, amassing US$ 78.98 million. It is projected to garner US$ 135.99 million by 2030 to expand at 7.0% CAGR during 2022-2030.

Based on country, the Europe fish vaccines market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the UK captured 28.8% share of Europe fish vaccines market in 2022. It was assessed at US$ 31.66 million in 2022 and is likely to hit US$ 56.59 million by 2030, exhibiting a CAGR of 7.5% during 2022-2030.

Key players operating in the Europe fish vaccines market are Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc., among others.

– In Aug 2020, Elanco Closes Acquisition of Bayer Animal Health.

– In Mar 2020, HIPRA and Skretting combine expertise to tackle devasting trout disease.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe fish vaccines market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe fish vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe fish vaccines market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Europe Fish Vaccine Market
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Fish Vaccine Market – Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Government Initiatives to Develop Aquaculture Industry
4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:
5. Fish Vaccine Market – Europe Market Analysis
5.1 Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
6. Europe Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
6.3.1 Overview
6.3.2 Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
6.4.1 Overview
6.4.2 Live Attenuated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
6.5.1 Overview
6.5.2 Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
6.6.1 Overview
6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
6.7.1 Overview
6.7.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7. Europe Fish Vaccine Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
7.3.1 Overview
7.3.2 Bacterial Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
7.4.1 Overview
7.4.2 Viral Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
7.5.1 Overview
7.5.2 Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8. Europe Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
8.3.1 Overview
8.3.2 Injection vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
8.4.1 Overview
8.4.2 Immersion Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9. Europe Fish Vaccine Market – Revenue and Forecast to 2030 – by Species
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
9.3.1 Overview
9.3.2 Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
9.4.1 Overview
9.4.2 Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
9.5.1 Overview
9.5.2 Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
9.6.1 Overview
9.6.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10. Europe Fish Vaccine Market – Country Analysis
10.1 Europe Fish Vaccine Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Europe Fish Vaccine Market, by Country
10.1.2.1 UK
10.1.2.1.1 Overview
10.1.2.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.1.5 UK: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.1.6 UK: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.2 Germany
10.1.2.2.1 Overview
10.1.2.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.2.5 Germany: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.2.6 Germany: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.3.4 France: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.3.5 France: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.3.6 France: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.4.5 Italy: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.4.6 Italy: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.5.5 Spain: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.5.6 Spain: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
11. Fish Vaccine Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Zoetis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 HIPRA SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Phibro Animal Health Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vaxxinova International BV
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Elanco Animal Health Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. UK Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 8. UK Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 9. UK Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 10. UK Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 11. Germany Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 12. Germany Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 13. Germany Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 14. Germany Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 15. France Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 16. France Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 17. France Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 18. France Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Italy Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 20. Italy Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 21. Italy Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 22. Italy Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 23. Spain Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 24. Spain Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 25. Spain Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 26. Spain Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 27. Rest of Europe Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 28. Rest of Europe Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
Table 29. Rest of Europe Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
Table 30. Rest of Europe Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
Table 33. Glossary of Terms, Fish Vaccine Market

LIST OF FIGURES

Figure 1. Europe Fish Vaccine Market Segmentation, By Country
Figure 2. Europe Fish Vaccine Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
Figure 5. Europe Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 6. Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Live Attenuated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Europe Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 12. Bacterial Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Viral Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Europe Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 16. Injected: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Immersion Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Oral Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 20. Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. Europe Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 25. Europe Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 26. UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 27. Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 29. Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 30. Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 31. Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 32. Growth Strategies in Fish Vaccine Market

The List of Companies – Europe Fish Vaccines Market

1. Elanco Animal Health Inc
2. Hipra SA
3. Merck & Co Inc.
4. Phibro Animal Health Corp
5. Vaxxinova International BV
6. Zoetis Inc.

Reviews

There are no reviews yet.

Be the first to review “Europe Fish Vaccines Market Forecast to 2030”